Header Logo

Connection

LUKASZ SZARPAK to Hallucinogens

Back to Details
This is a "connection" page, showing publications LUKASZ SZARPAK has written about Hallucinogens.
LUKASZ SZARPAK
Connection Strength
0.221
Hallucinogens
  1. Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials. Psychiatry Res. 2025 Feb; 344:116337.
    View in: PubMed
    Score: 0.221
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.